Harter Secrest & Emery LLP, a full-service business law firm with offices throughout New York, recently represented Maxim Group LLC in a registered direct offering of shares of common stock and a concurrent private placement of warrants to purchase common stock of Novo Integrated Sciences, Inc., raising total gross proceeds of approximately $8 million (before placement agent discounts, commissions, and estimated offering expenses).
The HSE Securities and Capital Markets team for the transaction included Alexander R. McClean, Sarah H. Brennan, Margaret K. Rhoda, and Kevin R. Pregent.
Maxim Group LLC, a leading full-service investment banking, securities and wealth management firm headquartered in New York, NY, provides a full array of financial services to a diverse range of corporate clients, institutional investors, and high net worth individuals. Novo Integrated Sciences, Inc. owns Canadian and U.S. subsidiaries which offer multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics, and rehabilitative science.
Harter Secrest & Emery is recognized as a leader in the securities and capital markets industry. With 10 attorneys devoted to practicing securities and capital markets law in western New York state, we bring a depth and breadth of experience unmatched in the region. The firm has represented issuers and underwriters in over 60 public offerings, with clients ranging from businesses seeking start-up capital to Fortune 500 companies. The firm’s securities practitioners assist clients with private and public offerings of securities, ongoing regulatory compliance and reporting, proxy solicitations, tender offers, and securities litigation and arbitration before the Securities and Exchange Commission, NYSE, Nasdaq, FINRA, and state and federal courts.
click here to view Harter Secrest & Emery Helps Maxim Group Close $8 Million Offering as a PDF